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Purpose: The incidence of cardiovascular events is higher in coronary artery disease
patients with type 2 diabetes (CAD+T2D) than in CAD patients without T2D. There is
increasing evidence that the recovery phase after exercise is a vulnerable phase for var-
ious cardiovascular events. We hypothesized that autonomic regulation differs in CAD
patients with and without T2D during post-exercise condition. Methods: A symptom-
limited maximal exercise test on a bicycle ergometer was performed for 68 CAD+T2D
patients (age 61± 5 years, 78% males, ejection fraction (EF) 67± 8, 100% on β-blockade),
and 64 CAD patients (age 62± 5 years, 80% males, EF 64± 8, 100% on β-blockade). Heart
rate (HR) recovery after exercise was calculated as the slope of HR during the ﬁrst 60 s
after cessation of exercise (HRRslope). R–R intervals were measured before (5min) and
after exercise from 3 to 8min, both in a supine position. R–R intervals were analyzed using
time and frequency methods and a detrended ﬂuctuation method (α1). Results: BMI was
30± 4 vs. 27± 3 kgm2 (p< 0.001); maximal exercise capacity, 6.5± 1.7 vs. 7.7± 1.9 METs
(p< 0.001); maximal HR, 128± 19 vs. 132± 18 bpm (p = ns); and HRRslope, −0.53± 0.17
vs. −0.62± 0.15 beats/s (p = 0.004), for CAD patients with and without T2D, respectively.
There was no differences between the groups in HRRslope after adjustment for METs, BMI,
and medication (ANCOVA, p = 0.228 for T2D and, e.g., p = 0.030 for METs). CAD+T2D
patients had a higher HR at rest than non-diabetic patients (57± 10 vs. 54± 6 bpm,
p = 0.030), but no other differences were observed in HR dynamics at rest or in post-
exercise condition. Conclusion:HR recovery is delayed in CAD+T2D patients, suggesting
impairment of vagal activity and/or augmented sympathetic activity after exercise. Blunted
HR recovery after exercise in diabetic patients comparedwith non-diabetic patients is more
closely related to low exercise capacity and obesity than to T2D itself.
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INTRODUCTION
The incidence of cardiovascular events is higher in coronary artery
disease patients (CAD) with type 2 diabetes (T2D) than in CAD
patientswithout T2D (Haffner et al., 1998; Junttila et al., 2010),but
the physiological or pathophysiological mechanisms causing these
differences are not well known. Altered autonomic regulation is
one potential mechanism resulting in the increased number of
cardiovascular events in CAD+T2D patients (Okada et al., 2010;
Pop-Busui et al., 2010; Lanza et al., 2011). Autonomic regulation
can be studied using various methods at the laboratory, or ambu-
latory condition tests such as passive head-up tilt and handgrip
tests (Montano et al., 1994; Tulppo et al., 2001, 2005; Fu et al.,
2002), or ambulatory heart rate (HR) variability and blood pres-
sure measurements (Pagani et al., 1985; Kleiger et al., 1987; Piira
et al., 2011). Analysis of autonomic regulation during and after
exercise has also been used in various physiological (Yamamoto
et al., 1991; Gregoire et al., 1996; Tulppo et al., 1996, 1998b) and
clinical settings (Cole et al., 1999, 2000; Jouven and Ducimetiere,
2000; Jouven et al., 2005; Kiviniemi et al., 2011).
There is increasing evidence that the recovery phase after exer-
cise is a vulnerable phase for various cardiovascular events. Case-
crossover studies have shown that exercise as a trigger of acute
myocardial infarction is not limited to the time of exercise, but
extends for a certain time period after cessation of physical activ-
ity (Siscovick et al., 1982, 1984; Albert et al., 2000; von Klot et al.,
2008). Similarly, the risk of sudden cardiac death is transiently
increased in the 30-min after vigorous exercise, and atrial ﬁbril-
lation episodes occur more commonly after rather than before
exercise (Siscovick et al., 1982, 1984; Coumel, 1994; Albert et al.,
2000; Huikuri, 2008). Measurement of autonomic function in the
very early phase of recovery after exercise has also provided prog-
nostic information. For example, delayed HR recovery 1–2min
after exercise has been shown to predict cardiovascular events in
the general population and in various patient groups and animal
studies (Cole et al., 1999; Lauer and Froelicher, 2002; Nissinen
et al., 2003; Jouven et al., 2005; Smith et al., 2005). Recently, we
have shown that co-activation of both autonomic arms may occur
during the recovery phase of exercise (Tulppo et al., 2011), which
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may partly explain the clustering of various cardiovascular events
in the recovery phase of exercise.
The present research was designed to study the behavior of
HR dynamics during exercise and in the recovery phase of exer-
cise in CAD patients with and without T2D, matched for age,
ejection fraction (EF), and sex. We hypothesized that autonomic
regulation,measured by HR recovery and HR variability methods,
differs in CAD patients with and without T2D, particularly during
post-exercise condition.
MATERIALS AND METHODS
SUBJECTS AND STUDY PROTOCOL
The present study was conducted in the Department of Exercise
and Medical Physiology at Verve (Oulu, Finland) and Oulu Uni-
versityHospital, and the patients were selected frompatients in the
ARTEMIS (Innovation to Reduce Cardiovascular Complications
of Diabetes at the Intersection) study database who had stable
CAD without (n = 64) and with T2D (n = 68). The exclusion cri-
teria were inability to perform the exercise stress test, unstable
angina at the time of recruitment, advanced age (>75 years), a
recent (<6months) myocardial infarction, severe nephropathy,
heart failure, scheduled cardiac revascularization therapy, T2D
diagnosed less than 6months from the beginning of study,diabetes
autonomic neuropathy, dementia, alcoholism, drug abuse, or any
condition that could impair the subject’s capacity to give informed
consent. CAD was documented by coronary angiography and
T2D was veriﬁed by oral glucose tolerance test according to cur-
rent recommendations (WHO, 1999). The study was performed
according to the Declaration of Helsinki, the local committees of
research ethics in the Northern Ostrobothnia Hospital District
(Oulu, Finland) approved the protocol, and all the subjects gave
written informed consent.
The laboratory measurements were performed in the Depart-
ment of Exercise and Medical Physiology atVerve (Oulu, Finland).
The patients were not allowed to eat or consume caffeine for 3 h
before the tests. Physical exercise and use of alcohol were prohib-
ited for 24 h before testing. Electrocardiography (ECG) and R–R
intervals were collected for 10min at supine rest, during exercise,
and 10min after exercise in supine position. Breathing was spon-
taneous in all phases. A capillary blood sample was obtained for
analysis of HbA1c concentration before testing (Aﬁnion™AS100,
Axis-Shield PoC AS, Oslo, Norway).
EXERCISE STRESS TEST
The patients performed an incremental maximal test on a bicy-
cle ergometer (Monark Ergomedic 839 E; Monark Exercise AB,
Vansbro, Sweden), starting at 30W with the work rate increasing
at a rate of 10 and 15W every 1min until exhaustion for females
and males, respectively. The patients moved to the supine posi-
tion within 30 s after cessation of exercise. The patients were not
allowed to move or talk during the recovery phase.
Ventilation (VE) and gas exchange (M909 Ergospirometer,
Medikro, Kuopio, Finland) were measured and reported as the
mean value for every minute. The highest 1-min mean value
of oxygen consumption was expressed as the peak oxygen con-
sumption (VO2peak). Maximal workload (W) and maximal METs
were calculated as average workload and METs during the last
1min of the test. ECG was monitored and recorded using a
standard 12-lead ECG (GE Healthcare, Cam-14, Waukesha, WI,
USA) and at the same time R–R intervals were recorded with
a Polar R–R recorder with a sampling frequency of 1,000Hz
(Polar Electro, Kempele, Finland). Blood pressure was mea-
sured with an electronic sphygmomanometer (Tango, Sun-Tech,
Raleigh, NC, USA) at rest and during exercise testing. The
patients were encouraged to reach a symptom-limited maxi-
mal workload, and exercise was stopped if ST depression was
>0.2mV.
The maximal HR was calculated as a mean value of 5 R–R
intervals before cessation of exercise from Polar R–R interval data
and converted to maximal HR in beats/min with the following
equation: maximal HR (beats/min)= 60·(mean R–R interval in
ms/1000)−1. The chronotropic response to exercise was calculated
by chronotropic response index (CRI) with the following equa-
tion: CRI= 100·(maximal HR− resting HR)·(220− age− resting
HR)−1 (Kiviniemi et al., 2011), and HR reserve as maximal
HR− resting HR. HR recovery values were calculated as mean
values of 5 R–R intervals around the time points of 15 (HRR15),
30 (HRR30), 60 (HRR60), and 120 (HRR120) s after cessation of
exercise from Polar data. Thereafter, HR recovery (beats/min) was
calculated as the change in HR from maximal HR to recovery
HR at the time points of 15, 30, 60, and 120 s after cessation
of exercise. The slope of HR during the 60-s after cessation of
exercise (HRRslope) was calculated by linear model using above
described HR values at the maximum and 15, 30, and 60 s time
points (Figure 1).
HEART RATE VARIABILITY
R–R intervals were analyzed from the last 5-min period at rest,
at every load during exercise (1-min periods), and from 3 to
8min (5-min) after exercise. Before HR variability analysis (using
FIGURE 1 | Example of heart rate recovery as the slope of heart rate
during the first 60 s after cessation of exercise for two patients (with
and without type 2 diabetes) with similar age and maximal heart rate.
The slope was calculated by linear model using mean values of 5 R–R
intervals [converted to the HR values in beats/min as 60·(mean R–R interval
in ms/100)−1] at maximum and around the time points of 15, 30, and 60 s
after cessation of exercise.
Frontiers in Physiology | Clinical andTranslational Physiology September 2011 | Volume 2 | Article 57 | 2
Neves et al. Heart rate recovery after exercise
Polar R–R data), all of the R–R intervals were edited manually
to exclude all premature beats and noise, which accounted for
<8% in every subject. ECG data was used during the editing to
conﬁrm sinus origin of the beats. An autoregressive model was
used to estimate the power spectrum densities of HR variability
after period level detrending (Huikuri et al., 1996; Tulppo et al.,
1996). The power spectra were quantiﬁed by measuring the area
under two frequency bands: LF power (0.04–0.15Hz) and HF
power (0.15–0.4Hz). Details of the spectrum analyses have been
described previously elsewhere (Task Force of the European Soci-
ety of Cardiology and the North American Society of Pacing and
Electrophysiology, 1996). Detrended ﬂuctuation analysis (DFA)
method was used to calculate fractal-like correlation properties
of the R–R interval data (Peng et al., 1995; Iyengar et al., 1996).
In this study the short-term (4–11 beats) scaling exponent (α-1)
was calculated based on previous experiments (Mäkikallio et al.,
1996).
STATISTICS
The data were presented as mean± SD. The normal Gaussian dis-
tribution of the data was veriﬁed with the Kolmogorov–Smirnov
goodness-of-ﬁt test (z value> 1.0). For repeated measurements
of post-exercise HR recovery (HRR15, HRR30, HRR60, HRR120),
two-factor ANOVA (time× group) was used to assess main effects
followed by post hoc comparison (unpaired t -test). Signiﬁcant
post hoc differences in HR recovery between the groups were
adjusted for maximal METs, BMI, and medications (calcium
antagonists and nitrates) using ANCOVA. For other variables, the
unpaired Student’s t -testwas used to assess the differences between
CAD and CAD+T2D groups in normally distributed data. The
Mann–Whitney U -test was used to assess the difference in HR
variability indices between groups. The Chi-square test was used
for categorical variables. The data were analyzed using SPSS soft-




The characteristics of the study population, including compar-
isons between diabetic and non-diabetic patients, are given in
Table 1. The diabetic patients’ body composition, e.g., weight
(p< 0.001), waist circumference (p< 0.001), BMI (p< 0.001),
and HbA1c (p< 0.001) differed from that of the non-diabetic
patients. However, blood pressure, EF, history of infarction, and
revascularization or smoking did not differ between the diabetic
and non-diabetic patients (Table 1). Medication did not differ
between the groups, except that calcium antagonists, nitrates, and
antidiabetics were more common among the diabetic than the
non-diabetic patients (Table 1).
HR RESPONSE TO MAXIMAL EXERCISE
The results of the maximal exercise test, including comparisons
between diabetic and non-diabetic patients, are given in Table 2.
Maximal exercise capacity was lower (p< 0.001) in the diabetes
patients, but maximal HR (p = 0.178) was at the same level com-
pared with the non-diabetic patients (Table 2). HR reserve was
smaller (p = 0.027) and CRI tended to be smaller (p = 0.057) in
Table 1 | Characteristics of patients.
CAD+T2D (n =68) CAD (n =64) p-Level
Sex (F/M) 15/53 13/51 p =0.488
Age (years) 61±5 62±5 p =0.514
Height (cm) 171±7 171±8 p =0.678
Weight (kg) 89±15 80±12 p<0.001
Waist (cm) 105±12 94±10 p<0.001
Hip (cm) 105±10 99±6 p<0.001
Waist/Hip ratio 1.00±0.07 0.95±0.07 p<0.001
BMI (kgm−2) 30±4 27±3 p<0.001
HbA1c (%) 6.0±0.7 5.5±0.2 p<0.001
SBP (mmHg) 138±18 136±16 p =0.672
DBP (mmHg) 82±10 82±8 p =0.875
HISTORY OFAMI
NSTEMI 18 (26%) 19 (30%) P =0.469
STEMI 13 (19%) 14 (21%) p =0.662
REVASCULARIZATION
CAGB 14 (21%) 13 (28%) p =0.506
PCI 42 (67%) 27 (59%) p =0.426
Current smokers 3 (4%) 8 (12%) p =0.147
LVEF (%) 67±8 65±8 p =0.107
MEDICATION
Anticougulants 66 (97%) 63 (98%) p =1.000
Beta blockers 68 (100%) 64 (100%) p =1.000
Calcium antagonists 20 (29%) 9 (14%) p =0.037
ACEI 31 (46%) 23 (36%) p =0.291
AT2 13 (19%) 14 (22%) p =0.830
Diuretics 26 (38%) 15 (23%) p =0.090
Statin 63 (93%) 57 (89%) p =0.553
Insulines 10 (7%) 0 (0%) p =0.001
Oral antidiabetics 50 (74%) 0 (0%) p<0.001
Nitrates 28 (41%) 8 (13%) p<0.001
Arrhythmia 1 (1%) 1 (1%) p =1.000
Values are mean±SD. BMI, body mass index; HbA1c, Glycosylated hemoglo-
bin; SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate;
AMI, acute myocardial infarction; NSTEMI, no-ST segment elevation myocardial
infarction; STEMI, ST segment elevation myocardial infarction; revascularized, the
patients who had at least one of the procedures (CABG, coronary artery by-pass
grafting or PCI, Percutaneus coronary intervention); LVEF, left ventricular ejec-
tion fraction; ACEI, angiotensin conversion enzyme inhibitor; AT2, angiotensin II
receptor blocker; CAD, coronary artery disease group; CAD+T2D, coronary artery
disease with type 2 diabetes.
the diabetic patients than in the non-diabetic patients. However,
therewerenot signiﬁcant differences betweengroups inHRreserve
or CRI after adjustment for maximal METs, BMI, and medica-
tion, e.g., forHR reserveANCOVA p = 0.686,p< 0.001,p = 0.126,
and p = 0.169 for diabetes, Mets, BMI, and calcium antagonists,
respectively. There was no difference between the groups in the
prevalence of ST segment depression>0.1mV during the exercise
test.
HR RECOVERY
Type 2 diabetes modiﬁed post-exercise HR recovery (main effect
for time× group interaction p = 0.037). The diabetic patients had
www.frontiersin.org September 2011 | Volume 2 | Article 57 | 3
Neves et al. Heart rate recovery after exercise
Table 2 | Maximal exercise capacity and heart rate recovery.
CAD+T2D (n =68) CAD (n =64) p-Level
Max load (W) 139±41 155±43 p =0.033
Max METs 6.5±1.7 7.7±1.9 p<0.001
MAXVO2PEAK
ml kg−1 min−1 21.6±5.8 25.9±6.5 p<0.001
lmin−1 1.89±0.52 2.05±0.58 p =0.101
Max ST
depression>1mm
32 (47%) 57 (49%) p =0.228
Max HR (bpm) 128±19 132±18 p =0.178
HR reserve (bpm) 70±20 78±18 p =0.027
CRI (bpm) 69±18 75±17 p =0.057
HR RECOVERY
15 s (bpm) 10.9±4.6 10.8±5.0 p =0.376
30 s (bpm) 15.8±7.0 17.8±6.9 p =0.098
60 s (bpm) 32.7±10.5 37.8±9.7 p =0.006
120 s (bpm) 44.3±13.4 48.9±11.1 p =0.037
Slope 60 (beats/s) −0.53±0.17 −0.62±0.14 p =0.004
Values are mean±SD. METs, metabolic equivalents; VO2peak, peak uptake
oxygen; HR, heart rate; CRI, maximal chronotropic response index.
delayed HRR60 (p = 0.006), HRR120 (p = 0.037), and HRRslope
(p = 0.004) compared with the non-diabetic patients (Table 2).
However, there were not signiﬁcant differences between groups
in HRR60, HRR120, or HRRslope after adjustment for maximal
METs, BMI, and medication, e.g., for HRR60 ANCOVA p = 0.223,
p = 0.061, p = 0.387, and p = 0.094 for diabetes, Mets, BMI, and
calcium antagonists, respectively. The corresponding p values for
HRR120 were p = 0.980, p = 0.001, p = 0.451, and p = 0.006 and
for HRRslope p = 0.228, p = 0.030, p = 0.404, and p = 0.079 for
diabetes,Mets,BMI,and calciumantagonists, respectively.Nitrates
did not modify HR behavior between groups at any condition.
Examples of HRRslope for non-diabetic and diabetic subjects are
shown in Figure 1.
HR AND HR VARIABILITY AT REST, DURING SUBMAXIMAL EXERCISE
AND AFTER EXERCISE
Heart rate and HR variability before and after exercise, includ-
ing comparisons between diabetic and non-diabetic patients, are
given in Table 3. Five diabetic patients were excluded from the
analysis due to the signiﬁcant number of extra systoles or techni-
cal artifacts in the R–R interval data. One non-diabetic patient was
excluded due to the extra systoles in both pre- and post-exercise
conditions and one in post-exercise condition due to the same
reason.
The diabetic patients had a higher HR in resting condition
than the non-diabetic patients (p = 0.030), but no other differ-
ences were observed at rest or in post-exercise condition (Table 3).
HRorHRvariability did not differ between the groups during sub-
maximal exercise at the levels of 40, 60, or 80% of maximal oxygen
uptake, e.g., HR was 92± 12 vs. 95± 14 bpm (p = 0.099) and α1
1.02± 0.37 vs. 1.02± 0.32 (p = 0.93) at the level of 61± 5% and
61± 5% of maximal oxygen uptake for diabetic and non-diabetic
patients, respectively.
Table 3 | Average values of linear and non-linear heart rate variability
before exercise (5min) and in post-exercise condition from 3 to 8min
after exercise, both in supine position.
CAD+T2D CAD p-Level
Pre-exercise 5min n =63 n =63
HR (bpm) 57±10 54±6 p =0.030
SDNN (ms) 36±19 36±21 p =0.969
HF power (ms2) 299±353 479±1347 p =0.490
LF power (ms2) 385±521 409±563 p =0.940
LF/HF ratio 1.81±1.71 1.47±1.34 p =0.210
α-1 1.04±0.27 0.99±0.26 p =0.280
Post-exercise 5min n =63 n =62
HR (bpm) 76±10 75±10 p =0.765
SDNN (ms) 29±12 28±17 p =0.386
HF power (ms2) 102±172 114±246 p =0.268
LF power (ms2) 162±212 175±352 p =0.608
LF/HF ratio 2.8±2.3 3.9±3.9 p =0.257
α-1 1.18±0.30 1.24±0.28 p =0.277
Values are mean±SD. HR, heart rate; SDNN, SD of normal-to-normal R–R inter-
vals; HF, high frequency power of R–R intervals; LF, low frequency power of R–R
intervals; α-1, fractal scaling exponent of R–R intervals.
DISCUSSION
The present study showed that post-exercise HR recovery was
slower inCAD+T2Dpatients than inCADpatients, suggesting an
impairment of vagal modulation and/or augmented sympathetic
activity initially after exercise for diabetic patients. The impaired
HR recovery in diabetic patients was the most obvious 1min after
exercise, documented by HRR60 and HRRslope indices. However,
blunted HR recovery initially after exercise in diabetic patients
compared with non-diabetic patients was more closely related to
lowexercise capacity andobesity than toT2D itself. Taken together,
these ﬁndings suggest that delayed HR recovery after exercise in
T2D patients may be reversible through prevention and treatment,
including, e.g., regular exercise and weight management.
POST-EXERCISE HR DYNAMICS
The interplay between sympathetic and vagal regulation of HR
during exercise is organized in a reciprocal fashion, i.e., increased
sympathetic activity is accompanied by decreased vagal activity in
the heart during dynamic exercise (Robinson et al., 1966; Maciel
et al., 1986; Orizio et al., 1988; Yamamoto and Hughson, 1991;
Tulppo et al., 1996, 1998b). However, this reciprocal behavior
is altered in the recovery phase after exercise due to temporal
differences in the recovery pattern of the autonomic arms in post-
exercise condition (Tulppo et al., 2011). A rapid restoration of
vagal activity occurs after cessation of exercise (Imai et al., 1994;
Goldberger et al., 2006; Martinmaki and Rusko, 2008; Tulppo
et al., 2011). On the contrary, the sympathetic nervous system
seems to have a longer latency to return to the baseline after
cessationof exercise, resulting in long-lastinghyperactivity of sym-
pathetic activity (Ray, 1993; Tulppo et al., 2011). Taken together,
these changes in autonomic regulation may result in dual activa-
tion of the sympathetic and vagal arms in post-exercise condition
Frontiers in Physiology | Clinical andTranslational Physiology September 2011 | Volume 2 | Article 57 | 4
Neves et al. Heart rate recovery after exercise
(Tulppo et al., 2011). These changes in autonomic activity in post-
exercise condition may partly explain the clinical ﬁndings, since
particularly the recovery phase of exercise has been shown to be a
vulnerable phase for various cardiovascular events (Siscovick et al.,
1982, 1984; Albert et al., 2000; von Klot et al., 2008).
It is well known that CAD+T2D patients are at a higher risk
for cardiac events than CAD patients without diabetes. Altered
autonomic regulation in post-exercise condition is one poten-
tial mechanism, since slow HR recovery after exercise has also
been associated with cardiovascular events in various clinical and
subclinical populations (Cole et al., 1999; Lauer and Froelicher,
2002; Nissinen et al., 2003; Jouven et al., 2005). In the present
study, HR recovery from 1 to 2min after exercise was the only
marker of autonomic activity separating diabetic andnon-diabetic
cardiac patients matched with age, sex, and EF all in optimal
medications, including β-blockade. Since a complex interaction
of autonomic regulation occurs in the initial phase after exercise,
it is difﬁcult to detect the difference in HR recovery between dia-
betic and non-diabetic patients due to impaired vagal activation
or augmented sympathetic activation or both.Also circulating cat-
echolamines have an important contribution for the sympathetic
post-exercise hyperactivity (Krock and Hartung, 1992), but unfor-
tunately we did not measure epinephrine or norepinephrine in the
present study. Thirdly, as a novel ﬁnding of the present study, there
were no differences between patients groups in HR recovery after
adjustment forMETs and BMI. These ﬁndings emphasized regular
exercise training and weight management as potential treatments
to improve post-exercise HR recovery in CAD+T2D patients.
Importantly, also calcium antagonists modiﬁed HR recovery par-
ticularly 2min after exercise. Patients with calcium antagonists
usually have more severe hypertension which is associated with
delayed HR recovery (Carnethon et al., 2011).
HR RESPONSE TO MAXIMAL EXERCISE
Measurement of the chronotropic response of HR to exercise
has been used to assess particularly sympathetic inﬂuence on the
heart and it has been shown to be a powerful predictor of car-
diac mortality in both asymptomatic populations (Azarbal et al.,
2004; Gulati et al., 2005; Jouven et al., 2005; Savonen et al., 2006;
Kiviniemi et al., 2011) and in patients with various cardiac diseases
(Myers et al., 2007; Savonen et al., 2008; Kiviniemi et al., 2011).
In the present study HR reserve was lower and the maximal
chronotropic response adjusted for age (CRI) tended to be lower
in CAD+T2D patients than in CAD patients without diabetes.
However, there were no differences between patients groups in
these indices after adjustment for ﬁtness and BMI.
HR VARIABILITY
Type 2 diabetes has been shown to decrease HR variability and
baroreﬂex sensitivity in T2D patients without CAD (Masaoka
et al., 1985; Frattola et al., 1997). There are previous studies where
T2D has shown no additional decrease in baroreﬂex sensitivity
among patients with CAD (Wykretowicz et al., 2005) or in HR
variability among T2D patients with heart failure or CAD (Burger
and Aronson, 2001; Kiviniemi et al., 2010). Also in the present
study the short-term HR variability indices measured at resting
or post-exercise condition were not able to separate CAD patients
with and without T2D. There are several potential explanations
for these ﬁndings. First, the populations are carefully matched
according to age, sex, EF, and β-blockade which all are known
to effect on HR variability and may partly explain the present
ﬁndings. Secondly, short-term HR variability measures at labora-
tory condition are not so well reproducible than 24-h recordings
(Huikuri et al., 1990; Tulppo et al., 1998b) and may be inﬂu-
enced by “white coat” effects in some subjects (Grassi et al., 1999).
Thirdly, high level of circulating norepinephrine particularly in
post-exercise condition may results in abrupt changes in beat-to-
beat R–R interval dynamics which are not detected by used HR
variability methods (Tulppo et al., 1998a). On the contrary to
HR variability measurements at rest or few minutes after exer-
cise, rapid and marked changes occurs in both autonomic arms
in tens of seconds from sympathetic dominance to restoration
of vagal activity resulting decreased HR after exercise (Tulppo
et al., 2011). The unique behavior of autonomic regulation initially
after maximal exercise is the major candidate to explain differ-
ences in HR recovery between diabetic and non-diabetic patient
groups.
STUDY LIMITATIONS
The measurements of the present study were performed under
continued prescribed medication because of ethical reasons
and the well known withdrawal effect of beta-block cessation.
However, the present results will have more practical implications
when the analyses are performed at a time when the patients are
on their normal medication.
CLINICAL APPLICATIONS
Based on the present study, it is important to emphasize the role
of physical exercise in maintaining good cardiovascular function,
improving physical performance, and losing weight. Although all
the patients were on optimized medication, it is important to
underscore that behavioralmodiﬁcation,exercises, anddiet should
be given priority similar to other preventive medications (Chow
et al., 2010).
CONCLUSION
Heart rate recovery 1min after exercise is the most powerful index
separating CAD patients with and without T2D in the modern
treatment era, beyond short-term HR variability measurements at
rest, during exercise, or in post-exercise condition. HR recovery
is delayed in CAD+T2D patients compared with CAD patients
without T2D, suggesting impairment of vagal activity and/or aug-
mented sympathetic activity after exercise. However, blunted HR
recovery initially after exercise in diabetic patients compared with
non-diabetic patients is more closely related to exercise capacity
and obesity than to T2D itself.
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